Manara - Qatar Research Repository
10.1111_and.14135.pdf (613.06 kB)

Endocrine contribution to the sexual dysfunction in patients with advanced chronic kidney disease and the role of hyperprolactinemia

Download (613.06 kB)
journal contribution
submitted on 2023-03-15, 08:04 and posted on 2023-03-16, 06:25 authored by Haitham Elbardisi, Ahmad Majzoub, Christiana Daniel, Fadwa Al.Ali, Mohamed Elesnawi, Kareim Khalafalla, Ashok Agarwal, Ralf Henkel, Alia Alattar, Ibrahim Al‐Emadi, Mohamed Arafa

In this study, we investigated the prevalence of sexual dysfunction among males with advanced chronic kidney disease and the effect of treating hyperprolactinemia among these patients. In this prospective study, patients were assessed with history, physical examination, hormonal assessment, and two questionnaires, IIEF and AIPE. Patients with hyperprolactinemia received treatment with cabergoline 0.5 mg once per week for 6 months and were re-evaluated. A total of 102 patients were included in this study, 75 (73.53%) were on hemodialysis, 13 (12.75%) on peritoneal dialysis and 14 (13.73%) on medical treatment alone. Ninety (88.24%) patients had premature ejaculation, 85 (83.33%) had anything from mild-to-moderate-to-severe erectile dysfunction. The incidence of hypogonadism and hyperprolactinemia was 34.4%. Patients treated with cabergoline (n = 26) showed a significant increase in LH levels (p = .003) and a significant decrease in prolactin levels (p = .003). Testosterone levels and the incidence of erectile dysfunction or premature ejaculation did not improve significantly. There is a high incidence of sexual dysfunction among patients. Treatment of hyperprolactinemia is effective in correcting prolactin levels, but does not improve erectile dysfunction or premature ejaculation. Therefore, treating hyperprolactinemia is not an overall effective treatment for erectile dysfunction in these patients.

Other Information

Published in: Andrologia
See article on publisher's website:



  • English



Publication Year

  • 2021

Institution affiliated with

  • Hamad Medical Corporation
  • Weill Cornell Medical College in Qatar

Usage metrics

    Manara - Qatar Research Repository



    Ref. manager